BAI, FRANCESCA
 Distribuzione geografica
Continente #
EU - Europa 5.342
NA - Nord America 5.316
AS - Asia 4.111
Continente sconosciuto - Info sul continente non disponibili 462
SA - Sud America 444
AF - Africa 118
OC - Oceania 23
Totale 15.816
Nazione #
US - Stati Uniti d'America 5.056
IT - Italia 1.656
GB - Regno Unito 1.373
SG - Singapore 1.155
CN - Cina 1.125
DE - Germania 566
BD - Bangladesh 539
HK - Hong Kong 345
BR - Brasile 333
FR - Francia 317
VN - Vietnam 312
RU - Federazione Russa 308
SE - Svezia 286
NL - Olanda 219
CA - Canada 185
IN - India 182
FI - Finlandia 180
TR - Turchia 116
ID - Indonesia 96
IE - Irlanda 92
ES - Italia 61
KR - Corea 50
JP - Giappone 40
PL - Polonia 35
UA - Ucraina 34
DK - Danimarca 32
CH - Svizzera 31
CI - Costa d'Avorio 31
AR - Argentina 29
MX - Messico 29
BE - Belgio 28
ZA - Sudafrica 26
AU - Australia 22
CO - Colombia 21
TW - Taiwan 21
IQ - Iraq 20
AT - Austria 19
CL - Cile 18
GR - Grecia 17
EU - Europa 15
EC - Ecuador 12
MY - Malesia 11
PK - Pakistan 11
TH - Thailandia 11
EG - Egitto 10
ET - Etiopia 10
MA - Marocco 10
PH - Filippine 10
UZ - Uzbekistan 10
VE - Venezuela 10
AE - Emirati Arabi Uniti 9
CZ - Repubblica Ceca 9
JM - Giamaica 9
NO - Norvegia 9
PT - Portogallo 8
GT - Guatemala 7
IR - Iran 7
LU - Lussemburgo 7
RO - Romania 7
IL - Israele 6
JO - Giordania 6
KE - Kenya 6
LT - Lituania 6
MK - Macedonia 6
PE - Perù 6
PY - Paraguay 6
RS - Serbia 6
TT - Trinidad e Tobago 6
AL - Albania 5
BG - Bulgaria 5
BO - Bolivia 5
HU - Ungheria 5
NG - Nigeria 5
SA - Arabia Saudita 5
AZ - Azerbaigian 4
CR - Costa Rica 4
HN - Honduras 4
SN - Senegal 4
TN - Tunisia 4
CD - Congo 3
CW - ???statistics.table.value.countryCode.CW??? 3
EE - Estonia 3
HR - Croazia 3
PS - Palestinian Territory 3
SC - Seychelles 3
SV - El Salvador 3
UY - Uruguay 3
BS - Bahamas 2
DZ - Algeria 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LV - Lettonia 2
MO - Macao, regione amministrativa speciale della Cina 2
NI - Nicaragua 2
PA - Panama 2
PR - Porto Rico 2
UG - Uganda 2
VG - Isole Vergini Britanniche 2
A2 - ???statistics.table.value.countryCode.A2??? 1
Totale 15.350
Città #
Southend 1.222
Singapore 665
Ashburn 597
Dallas 457
Milan 400
Chandler 333
Hong Kong 313
San Jose 275
Frankfurt am Main 244
Fairfield 240
Beijing 210
Council Bluffs 195
Santa Clara 155
Wilmington 153
Ann Arbor 151
Los Angeles 151
Rome 130
New York 128
Seattle 123
Helsinki 115
Houston 114
Woodbridge 107
Princeton 100
Ho Chi Minh City 91
Dublin 88
Toronto 88
Hefei 87
Jakarta 77
Boardman 76
Hanoi 76
Buffalo 69
Cambridge 64
Lauterbourg 63
Munich 61
Moscow 60
Dearborn 59
The Dalles 58
Bengaluru 55
Istanbul 50
Turin 49
Guangzhou 47
Columbus 44
Phoenix 44
Shanghai 40
Nanjing 38
Naples 37
Chicago 36
Groningen 36
Cagliari 33
São Paulo 33
Tokyo 33
Des Moines 32
Florence 32
Abidjan 31
Mountain View 31
Redwood City 28
Cangzhou 25
Nuremberg 25
Palermo 24
Seoul 24
Warsaw 24
Brussels 23
Grafing 23
Bologna 22
Mumbai 22
Turku 22
Lappeenranta 21
San Diego 21
London 20
Madrid 20
Redmond 20
Amsterdam 19
Da Nang 19
Hangzhou 18
Atlanta 17
Shenzhen 17
Washington 17
Orem 16
Paris 16
Berlin 15
Catania 15
Genoa 15
Kiez 15
Montreal 15
Montréal 15
Boston 14
Quanzhou 14
Tianjin 14
Bari 13
Fuzhou 13
Haiphong 13
Shenyang 13
Stockholm 13
Taipei 13
Zhengzhou 13
Jacksonville 12
Jinan 12
Perugia 12
Pescara 12
Vienna 12
Totale 9.082
Nome #
HIV-ASSOCIATED NEUROCOGNITIVE DISORDERS (HAND): PERFORMANCE OF ¿3 QUESTIONS TEST¿ AS SCREENING TEST, PREVALENCE, CLINICAL CORRELATES AND THERAPEUTIC APPROACH IN THE SAN PAOLO INFECTIOUS DISEASES¿ (SPID) COHORT. 788
Efficacy and safety of dalbavancin in the treatment of acute bacterial skin and skin structure infections (ABSSSIs) and other infections in a real-life setting: data from an Italian observational multicentric study (DALBITA study). 480
HPV infection in a cohort of HIV-positive men and women : prevalence of oncogenic genotypes and predictors of mucosal damage at genital and oral sites 404
Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy 395
Maraviroc as Intensification Strategy in HIV-1 Positive Patients with Deficient Immunological Response: an Italian Randomized Clinical Trial 386
T-Cell Phenotypes, Apoptosis and Inflammation in HIV+ Patients on Virologically Effective cART with Early Atherosclerosis 380
Switching from efavirenz to rilpivirine improves sleep quality and self-perceived cognition but has no impact on neurocognitive performances : results from a randomized controlled trial 355
Factors associated with HPV-DNA clearance in a cohort of HIV-positive patients : role of cART and gender 332
Reduced central memory CD4+ T cells and increased T-Cell activation characterise treatment-naive patients newly diagnosed at late stage of HIV infection 326
Impact of psychological intervention on anxiety, depression, and post-traumatic stress disorder: results from a longitudinal study of hospitalized Covid-19 patients = Impatto di un intervento psicologico su ansia, depressione e disturbo post-traumatico da stress: risultati di uno studio longitudinale su pazienti Covid-19 ospedalizzati 319
Circulating sCD14 is associated with virological response to pegylated-interferon-alpha/ribavirin treatment in HIV/HCV co-infected patients 319
Evidence for polymicrobic flora translocating in peripheral blood of HIV-infected patients with poor immune response to antiretroviral therapy 310
Assessment of radiological vertebral fractures in HIV-infected patients : clinical implications and predictive factors 306
Virological response and retention in care according to time of starting ART in Italy: Data from the Icona Foundation Study cohort 299
A 20-year-old girl with an unusual febrile illness 295
Cognitive Neuro-Rehabilitation of HIV-Associated Neurocognitive Disorders : Case Reports of A New Computer-Based Restorative Approach In 3 Hiv-Positive Cart-Treated Patients 289
Association between abdominal aortic calcifications, bone mineral density and vertebral fractures in a cohort of HIV-positive patients 284
Long-Term Suppressive cART Is Not Sufficient to Restore Intestinal Permeability and Gut Microbiota Compositional Changes 276
Viro-immunological characterization of naïve patients with high cerebrospinal fluid (CSF) HIV RNA 272
Sensitivity of SARS-CoV-2 Detection With Nasopharyngeal Swabs 264
Projections of non-communicable disease and health care costs among HIV-positive persons in Italy and the U.S.A. : a modelling study 261
Association between CSF and peripheral markers of immune-activation/inflammation and elevated intrathecal HIV-RNA levels in a cohort of HIV-infected antiretroviral naıve individuals 258
Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohort 255
Skewed T-cell maturation and function in HIV-infected patients failing CD4+ recovery upon long-term virologically suppressive HAART 253
Declining mortality rate of hospitalised patients in the second wave of the COVID-19 epidemics in Italy : Risk factors and the age-specific patterns 245
Clinical and viro-immunological correlates of HIV associated neurocognitive disorders (HAND) in a cohort of antiretroviral-naïve HIV-infected patients 244
CD8+ hyperactivation and senescence correlate with early carotid intima-media thickness in HIV+ patients with no cardiovascular disease 239
The importance of patients’ case-mix for the correct interpretation of the hospital fatality rate in COVID-19 disease 230
The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort 230
Long-lasting cognitive abnormalities after COVID-19 228
Persistence of High Percentage of Peripheral Activated CD8+ T Cells Predict Cytologic HPV-Related Dysplasia in cART-Treated, HIV-Positive Subjects 221
Female gender is associated with long COVID syndrome : a prospective cohort study 220
Real World Estimate of Vaccination Protection in Individuals Hospitalized for COVID-19 211
Proportion and factors associated with recent HIV infection in a cohort of patients seen for care in Italy over 1996-2014: Data from the ICONA Foundation Study cohort 209
Multi-layered deep immune profiling, SARS-CoV-2 RNAemia and inflammation in unvaccinated COVID-19 individuals with persistent symptoms 204
Clinical effect of interleukin-2 (IL-2) immuno-adjuvant treatment in HIV+ advanced naïve patients 202
Reduced CD127 expression on peripheral CD4+ T cells impairs immunological recovery in course of suppressive HAART 200
Do combination antiretroviral therapy regimens for HIV infection feature diverse T-Cell phenotypes and inflammatory profiles? 194
One‐Year Cognitive Follow‐Up of COVID‐19 Hospitalized Patients 193
One-pill once-a-day HAART: A simplification strategy that improves adherence and quality of life of HIV-infected subjects 184
Monoclonal antibodies against SARS-CoV-2 to prevent COVID-19 worsening in a large multicenter cohort 183
Immune reconstitution in HIV+ subjects on Lopinavir/Ritonavir-based HAART according to the severity of pre-therapy CD4+ 183
Psychological outcomes after hospitalization for COVID-19: data from a multidisciplinary follow-up screening program for recovered patients 177
Learning from post-COVID-19 condition for epidemic preparedness: a variable catalogue for future post-acute infection syndromes 171
Association between tight junction proteins and cognitive performance in untreated persons with HIV 167
Evolution of the prevalence of hepatitis C virus infection and hepatitis C virus genotype distribution in human immunodeficiency virus-infected patients in Italy between 1997 and 2015 165
Short and long-term trajectories of the post COVID-19 condition: Results from the EuCARE POSTCOVID study 164
Anxiety and depression symptoms after virological clearance of COVID-19: A cross-sectional study in Milan, Italy 163
CD8 T-cell activation is associated with lipodystrophy and visceral fat accumulation in antiretroviral therapy-treated virologically suppressed HIV-infected patients 160
Peripheral and cerebrospinal fluid immune activation and inflammation in chronically HIV-infected patients before and after virally suppressive combination antiretroviral therapy (cART) 159
ORCHESTRA Delphi consensus: clinical management of SARS-CoV-2 infection in people with HIV 152
Development and validation of a prediction score for failure to casirivimab/imdevimab in hospitalized patients with COVID-19 pneumonia 150
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort 149
CX3CR1 I249M280 heterozygosity is associated to contraction of HIV-specific immune responses in HIV-infected patients failing to recover CD4T-cell following long-term haart 146
Incidence, risk factors and impact on clinical outcomes of bloodstream infections in patients hospitalised with covid-19: A prospective cohort study 146
A Quantitative Estimate of the Expected Shortening of the Median Isolation Period of Patients With COVID-19 After the Adoption of a Symptom-Based Strategy 145
Effectiveness of hydroxychloroquine in COVID-19 disease : a done and dusted deal? 137
Effectiveness of Anti-SARS-CoV-2 monoclonal antibodies in real-life: RNAemia and clinical outcomes in high-risk COVID-19 patients 134
EuCARE-POSTCOVID Study: a multicentre cohort study on long-term post-COVID-19 manifestations 134
Cost analysis of dalbavancin versus standard of care for the treatment of acute bacterial skin and skin structure infections (ABSSSIs) in two Italian hospitals 133
EuCARE-hospitalised study protocol: a cohort study of patients hospitalised with COVID-19 in the EuCARE project 130
In-hospital mortality during the wild-type, alpha, delta, and omicron SARS-CoV-2 waves: a multinational cohort study in the EuCARE project 127
Bacterial and Viral Coinfections in Adult Patients Hospitalized With COVID-19 Throughout the Pandemic: A Multinational Cohort Study in the EuCARE Project 126
SARS-CoV-2 mRNA Vaccine Response in People Living with HIV According to CD4 Count and CD4/CD8 Ratio 121
Long-lasting cognitive impairment after COVID-19 119
Immunologic characterization of a patient with clinical and virologic rebound upon Nirmatrelvir/Ritonavir treatment: the unfortunate epilogue of COVID-19 117
Prevalence of sub-clinical vertebral fractures in a cohort of HIV positive patients and ability of frax-score to identify patients at increased fracture risk 109
Renal microsporidiosis due to Encephalitozoon cuniculi in an HIV/AIDS patient with persistent fever and kidney injury 102
Timed short messaging service improves adherence and virological outcomes in HIV-1-infected patients with suboptimal adherence to antiretroviral therapy 93
Cerebrospinal fluid HIV-1 escape according to different thresholds and underlying comorbidities : Is it time to assess the definitions? 79
OC-30 Scant effect of cART on mucosal immune cells during acute HIV infection 9
null 3
null 3
Totale 15.816
Categoria #
all - tutte 42.685
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.685


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.030 0 0 82 70 92 80 79 87 158 146 54 182
2022/20231.256 114 132 100 149 144 199 34 86 142 30 87 39
2023/20241.066 56 48 45 81 251 83 90 61 39 61 110 141
2024/20252.528 114 194 74 230 165 131 146 181 155 320 325 493
2025/20265.861 563 583 599 446 451 293 690 227 478 345 730 456
2026/2027620 313 298 9 0 0 0 0 0 0 0 0 0
Totale 15.816